GlaxoSmithKline Pharmaceuticals informs about change in senior managerial personnel
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), GlaxoSmithKline Pharmaceuticals has informed that the Vinay Subramanian, Commercial Head – Oncology would be part of leadership team effective 20th April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed.
The above information is a part of company’s filings submitted to BSE.
